Risperdal Consta Kit
NDC 50458-308
Product Information
Risperdal Consta (risperidone) is a NDA-approved product labeled by Janssen Pharmaceuticals, Inc.. Risperidone is used to treat certain mental/mood disorders (schizophrenia, bipolar disorder). It is supplied as a kit. This product entry covers the primary NDC 50458-308 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 50458-308?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- RISPERIDONE (UNII: L6UH7ZF8HC)
- RISPERIDONE (UNII: L6UH7ZF8HC) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- POLYSORBATE 20 (UNII: 7T1F30V5YH)
- CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED (UNII: K679OBS311)
- SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE (UNII: 70WT22SF4B)
- ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)
- SODIUM CHLORIDE (UNII: 451W47IQ8X)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 402010 - risperiDONE 25 MG Extended Release Injection
- RxCUI: 402010 - risperidone 25 MG Injection
- RxCUI: 402011 - risperiDONE 37.5 MG Extended Release Injection
- RxCUI: 402011 - risperidone 37.5 MG Injection
- RxCUI: 402012 - risperiDONE 50 MG Extended Release Injection
* Please review the full disclaimer at the bottom of this page.
Patient Education
Risperidone Injection
Risperidone extended-release (long-acting) injection is used to treat schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Risperidone extended-release injection is used alone or in combination with lithium (Lithobid) or valproate (Depacon) to treat people who have bipolar I disorder (manic depressive disorder; a disease that causes episodes of depression, episodes of severe mania, and other abnormal moods). Risperidone is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.
[Learn More]
* Please review the full disclaimer at the bottom of this page.